Research Article

The Prognostic Effect of Serum Albumin Level on Outcomes of Hospitalized COVID-19 Patients

Table 1

Case status and demographic and clinical characteristics of patients with COVID-19, with and without in-hospital mortality.

VariableAll patientsPatients with in-hospital mortalityPatients without in-hospital mortality value

Age mean (sd), yr61.5 (15.3)65.3 (16.11)59.9 (15.4)0.006
Male59.7 (14.4)63.1 (14.4)57.9 (14.2)
Female64 (16.2)70.9 (12.4)62.3 (16.6)

Sex, no./total no. (%)
Male178/300 (59%)63/87 (72%)115/213 (53%)0.003
Female122/300 (41%)24/87 (28%)98/213 (46%)

Race, no./total no. (%)
African American133/300 (44%)37/87(43%)96/213(45%)0.687
Hispanic125/300 (42%)36/87(41%)89/213 (42%)
White21/300 (7%)7/87 (8%)14/213 (7%)
Other21/300 (7%)7/87(8%)14/213 (7%)

BMI, mean (SD) (kg/m2)30.9 (7.8)30.5 (7.1)31 (8)0.749
Obesity (BMI ≥30)140/300(47%)41/87 (47%)99/213(46%)0.919
GFR (<60)151/300 (50%)59/87 (68%)92/213(43%)0.001
AKI124/300 (41%)55/87 (63%)69/213 (32%)0.001
DM125/300 (42%)42/87 (49%)83/213 (39%)0.138
HTN190/300 (63%)52/87 (60%)138/213 (65%).0413
CAD32/300 (11%)10/87 (11%)22/213 (10%)0.767
COPD25/300 (6.2%)5/87 (6%)20/213 (9%)0.300
AF15/300 (5%)4/87 (5%)11/213 (5%)0.838
CHF37/300(12%)21/213 (10%)16/87(18%)0.041
ICU admission99/300 (33%)64/87 (74%)35/213 (16%)0.001
Albumin, mean (SD)2.86(0.5)2.6 (0.49)2.9(0.48)0.001
CRP10.7 (8.3)8.8 (6.5)15.7 (10)0.001
Lymphocytes0.95 (0.5)0.89 (0.5)0.97 (0.5)0.183
D-dimer (Mic/L)4237 (12623)3120 (8835)7036 (188850)0.024
Ferritin1269 (2739)852 (846)2280 (4767)0.001
Lactic acid2.1 (1.8)1.9 (1.7)2.4 (2)0.046

BMI: body mass index, GFR: glomerular filtration rate, AKI: acute kidney injury, DM: diabetes mellitus, HTN: hypertension, CAD: coronary artery disease, COPD: chronic obstructive pulmonary disease, AF: atrial fibrillation, CHF: congestive heart failure, CRP: C-reactive protein.